CJC-1295 NO DAC (Mod GRF 1-29) (5mg) Research Peptide: A Short‑Acting GHRH Analog for Pulsatile GH & IGF‑1 Studies

If your research investigates the dynamics of growth hormone (GH) secretion, the regulation of the hypothalamic‑pituitary‑somatotropic axis, or the physiological effects of pulsatile GH release, CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide offers a precisely defined and mechanistically valuable synthetic tool.

CJC-1295 NO DAC (Mod GRF 1-29) (5mg) — is a short‑acting, tetrasubstituted 29‑amino‑acid analogue of growth hormone‑releasing hormone (GHRH). Unlike its DAC‑conjugated counterpart, which provides sustained, continuous GHRH receptor engagement, CJC‑1295 NO DAC has a half‑life of approximately 30 minutes and supports a pulsatile release pattern that closely replicates the natural, physiological secretion of growth hormone. This makes CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide a valuable tool for laboratories investigating endocrine signalling, metabolic regulation, and the comparative pharmacology of short‑ versus long‑acting GHRH analogues.

At Wuhan Top Miracle Peptides, we supply high‑purity CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥98% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into GH dynamics, IGF‑1 signalling, and metabolic research begin with uncompromising quality.

What Is CJC-1295 NO DAC (Mod GRF 1-29) (5mg) and How Does It Work?

To fully appreciate the research potential of CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide, it is essential to understand its biochemical structure and the mechanism by which it achieves pulsatile GH stimulation.

The Tetrasubstituted 29‑Amino‑Acid GHRH Analog

CJC-1295 NO DAC (Mod GRF 1-29) (5mg) is a synthetic 29‑amino‑acid peptide derived from the first 29 amino acids of endogenous growth hormone‑releasing hormone (GHRH), the shortest fully functional fragment of the native hormone. The peptide features four specific amino acid substitutions — at positions 2, 8, 15, and 27 — that confer resistance to enzymatic degradation, particularly by dipeptidyl peptidase‑4 (DPP‑IV). These modifications include D‑Alanine at position 2, which is a key alteration that prevents rapid degradation by DPP‑IV. Its molecular formula is C₁₅₂H₂₅₂N₄₄O₄₂, with a molecular weight of approximately 3,367.97 g/mol and a CAS number of 863288‑34‑0.

The defining feature of CJC‑1295 NO DAC is the absence of the Drug Affinity Complex (DAC) moiety. Without DAC, the peptide cannot covalently bind to serum albumin, and therefore has a short half‑life of approximately 30 minutes. This short duration is not a limitation for pulsatile GH release models; rather, it is a deliberate design feature that supports research into the body’s natural, pulsatile GH secretion patterns.

Mechanism of Action: Pulsatile GHRH Receptor Activation

The biological activity of CJC-1295 NO DAC (Mod GRF 1-29) (5mg) research peptide is mediated through its short‑lived activation of the GHRH receptor:

• GHRH Receptor Binding: CJC‑1295 NO DAC binds to GHRH receptors (GHRH‑R) located on somatotroph cells in the anterior pituitary gland.

• cAMP/PKA Signalling Cascade: Receptor activation stimulates adenylyl cyclase to convert ATP into cyclic AMP (cAMP). The increase in intracellular cAMP activates Protein Kinase A (PKA), which phosphorylates downstream targets.

• Pulsatile GH Synthesis and Secretion: This signalling cascade culminates in the synthesis and secretion of growth hormone (GH) in a pulsatile manner that mimics the body’s natural rhythm.

• IGF‑1 Elevation: The released GH stimulates the liver to produce insulin‑like growth factor 1 (IGF‑1).

Research Note: NO DAC vs. DAC Distinction

The absence of the DAC moiety fundamentally distinguishes CJC‑1295 NO DAC from its DAC‑conjugated counterpart. CJC‑1295 NO DAC has a short half‑life of approximately 30 minutes and supports a pulsatile release pattern that mimics natural physiology. CJC‑1295 with DAC has a half‑life of 6‑8 days and produces a sustained, continuous GH bleed. For research models that aim to study the physiological effects of pulsatile GH release — rather than sustained elevation — the NO DAC variant is the preferred tool.

Key Research Applications for CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg)

CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.

1. Pulsatile GH & IGF‑1 Signalling Research

The defining feature of CJC‑1295 NO DAC—its short half‑life and pulsatile action—makes it a valuable tool for studying physiological GH secretion patterns. Research applications include:

• Pulsatile GH Dynamics: Investigating the amplitude, frequency, and physiological significance of pulsatile GH release.

• IGF‑1 Elevation Studies: Studying the relationship between GH pulses and IGF‑1 production.

• Comparative Pharmacokinetics: Comparing the effects of short‑acting (NO DAC) versus long‑acting (DAC) GHRH analogues on GH secretion patterns.

2. Metabolic & Body Composition Research for CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

CJC‑1295 NO DAC has been investigated for its effects on metabolism and body composition:

• Lipolysis and Fat Metabolism: Increased levels of GH are presumed to increase lipolysis (fat loss) in research models.

• Muscle Growth and Protein Synthesis: GH influences protein building and muscle tissue development.

• Metabolic Regulation: Studying the metabolic effects of GH modulation, including mitochondrial function and oxidative stress reduction.

3. Receptor Pharmacology & Signal Transduction Research

As a short‑acting GHRH analogue, CJC‑1295 NO DAC serves as a molecular probe for studying GHRH receptor pharmacology:

• Receptor Binding Studies: Characterising the binding affinity and kinetics of GHRH‑R engagement.

• Signal Transduction: Dissecting the cAMP/PKA signalling cascade activated by transient GHRH receptor engagement.

• Receptor Desensitisation: Investigating the potential for receptor down‑regulation following repeated, short‑lived activation.

4. Synergistic Combination Studies for CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

Research indicates that combining CJC‑1295 NO DAC with other GH secretagogues may result in synergistic interactions:

• GHRP‑2 and Ipamorelin Combinations: GHRP‑2 and Ipamorelin stimulate GH release through pathways distinct from GHRH, possibly involving ghrelin receptors.

• Amplified GH Release: When exposed to research models in conjunction, these peptides have been hypothesised to amplify each other’s impacts, leading to a more pronounced increase in endogenous GH levels.

5. Neuroendocrine & Endocrine Research for CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

CJC‑1295 NO DAC is used to study the neuroendocrine regulation of the GH axis:

• Hypothalamic‑Pituitary Axis: Investigating the feedback mechanisms that regulate GH secretion, including somatostatin and IGF‑1 negative feedback loops.

• Circadian GH Rhythm: Studying how pulsatile GHRH stimulation affects the natural circadian rhythm of GH secretion.

Chemical & Physical Specifications for CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

Accurate characterisation of CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide is essential for reproducible experimental design.

Note: The 5 mg mass refers to the weight of the peptide in its lyophilised form. CJC‑1295 NO DAC is typically supplied as a TFA or acetate salt, which enhances aqueous solubility. The peptide does not contain the Drug Affinity Complex (DAC) moiety, which is why it has a short half‑life and supports pulsatile GH release.

Reconstitution & Handling Protocol for CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg)

Proper reconstitution of CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide is critical for maintaining its structural integrity and biological activity.

Step 1 – Preparation

• Bring the sealed CJC‑1295 NO DAC vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the CJC-1295 NO DAC (Mod GRF 1-29) (5mg) vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 5 mg per 0.5‑1 mL of diluent, yielding a 5‑10 mg/mL stock solution.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage for CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

• Immediately after dissolution, aliquot the reconstituted CJC‑1295 NO DAC into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table for CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

Adjust diluent volume based on your experimental requirements. For cell culture applications, typical working concentrations may range from 0.1‑10 µM.

Storage & Stability Guidelines for CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

Why Choose Wuhan Top Miracle Peptides for CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg)?

As an authentic licensed peptide supplier based in the United Kingdom, we supply CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥98% for every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• UK‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO).

Researchers across the United Kingdom—including those at leading institutions in London, Cambridge, Oxford, Manchester, and Edinburgh—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) Research Peptide

What is CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide?
CJC‑1295 NO DAC (also known as Modified GRF 1‑29) is a synthetic 29‑amino‑acid analogue of growth hormone‑releasing hormone (GHRH) that does not contain a Drug Affinity Complex (DAC) moiety. It has a short half‑life of approximately 30 minutes and supports a pulsatile release pattern that mimics the body’s natural GH secretion.

What is the sequence and molecular weight of CJC‑1295 NO DAC?
CJC‑1295 NO DAC is a tetrasubstituted 29‑amino‑acid GHRH analog with modifications at positions 2, 8, 15, and 27. Its molecular formula is C₁₅₂H₂₅₂N₄₄O₄₂, and its molecular weight is approximately 3,367.97 g/mol.

What are the primary research applications for CJC‑1295 NO DAC?
CJC‑1295 NO DAC is used in pulsatile GH and IGF‑1 signalling research, metabolic and body composition research (lipolysis, muscle growth), receptor pharmacology and signal transduction studies, synergistic combination studies with GHRP‑2 and Ipamorelin, and neuroendocrine research.

What is the mechanism of action of CJC‑1295 NO DAC?
CJC‑1295 NO DAC binds to GHRH receptors on pituitary somatotrophs, activating a G‑protein signalling cascade that increases cAMP, activates PKA, and stimulates GH synthesis and secretion in a pulsatile manner that mimics natural physiology.

How does CJC‑1295 NO DAC differ from CJC‑1295 with DAC?
CJC‑1295 NO DAC has a half‑life of 30 minutes and supports pulsatile GH release. CJC‑1295 with DAC has a half‑life of 6‑8 days and produces a sustained, continuous GH bleed.

What purity does your CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) meet?
Our CJC‑1295 NO DAC is tested to ≥98% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg)?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake.

How should I store reconstituted CJC‑1295 NO DAC?
Reconstituted CJC‑1295 NO DAC should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

Is CJC-1295 NO DAC (Mod GRF 1-29) (5mg) research peptide legal to purchase in the UK?
Yes. CJC‑1295 NO DAC is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United Kingdom for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: CJC‑1295 is not approved for human use and is banned by the World Anti‑Doping Agency (WADA) for athletic use.

Does Wuhan Top Miracle Peptides ship internationally?
Yes. We ship across the EU (France, Germany, Spain, Sweden, Italy) and to the USA from our UK warehouse. Wholesale pricing is available for bulk orders.

Wholesale CJC-1295 NO DAC (Mod GRF 1-29) (5mg) Supply Across the UK and Europe

Wuhan Top Miracle Peptides supports wholesale peptide buyers in the United Kingdom and international markets.

We Support Enquiries From:

• United Kingdom
• France
• Germany
• Spain
• Sweden
• Italy
• USA
• Wider Europe

For larger CJC-1295 NO DAC (Mod GRF 1-29) (5mg) enquiries, contact our team before ordering. This helps confirm stock, documentation, shipping options, No DAC status, Mod GRF 1-29 identity, and buyer verification requirements.

Where to Source CJC-1295 NO DAC (Mod GRF 1-29) (5mg) in the UK

If you are searching for where to source CJC-1295 NO DAC (Mod GRF 1-29) (5mg) in the UK, Wuhan Top Miracle Peptides provides a simple professional enquiry process.

Professional Enquiry Process

1. Review the CJC-1295 NO DAC (Mod GRF 1-29) (5mg) product details.
2. Check the current label and batch information.
3. Confirm whether the batch is listed as CJC-1295 No DAC, CJC-1295 without DAC, or Mod GRF 1-29.
4. Confirm No DAC status.
5. Ask about COA and purity-related documentation.
6. Confirm the sequence and salt form where required.
7. Confirm storage information and shipping country.
8. Discuss wholesale quantity requirements.
9. Complete buyer verification where required.
10. Place a professional enquiry with support from our team.

CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

Bulk Peptides Page
Shipping & Returns Page
Contact Us Page
Shop Page
Quality / Compliance Page
CJC-1295 DAC Product Page
Mod GRF 1-29 Product Page
CJC-1295 Ipamorelin Blend Page
PubChem / compound reference source
Scientific or compound reference source
GOV.UK / MHRA
Google Search Central
ASA / CAP Code Section 12

CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

From its design as a tetrasubstituted, short‑acting GHRH analogue to its well‑documented role in supporting pulsatile GH release and IGF‑1 signalling, CJC‑1295 NO DAC (Mod GRF 1‑29) (5mg) research peptide provides a precisely defined and pharmacologically valuable platform for advanced endocrinological and metabolic research. Its ability to support pulsatile GH release — rather than sustained elevation — makes it a valuable tool for laboratories investigating physiological GH dynamics, receptor pharmacology, and the comparative effects of short‑ versus long‑acting GHRH analogues. By choosing high‑purity, lab‑verified CJC-1295 NO DAC (Mod GRF 1-29) (5mg) research peptide from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with CJC-1295 NO DAC (Mod GRF 1-29) (5mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade CJC-1295 NO DAC (Mod GRF 1-29) (5mg) delivered directly to your facility in the UK, EU, or USA.